Molecular Changes in the Vasculature of Injured Tissues

Folkman, 2006, Angiogenesis, Annu Rev Med, 57, 1, 10.1146/annurev.med.57.121304.131306 Falanga, 2005, Wound healing and its impairment in the diabetic foot, Lancet, 366, 1736, 10.1016/S0140-6736(05)67700-8 Martin, 1997, Wound healing—aiming for perfect skin regeneration, Science, 276, 75, 10.1126/science.276.5309.75 Wickström, 2003, Matrix reloaded to circulation hits the tumor target, Cancer Cell, 3, 513, 10.1016/S1535-6108(03)00143-0 St. Croix, 2000, Genes expressed in human tumor endothelium, Science, 289, 1197, 10.1126/science.289.5482.1197 Ruoslahti, 2002, Specialization of tumour vasculature, Nat Rev Cancer, 2, 83, 10.1038/nrc724 Friedlander, 1996, Involvement of integrins αvβ3 and αvβ5 in ocular neovascular diseases, Proc Natl Acad Sci USA, 93, 9764, 10.1073/pnas.93.18.9764 Gerlag, 2001, Suppression of murine collagen-induced arthritis by targeted apoptosis of synovial neovasculature, Arthritis Res, 3, 357, 10.1186/ar327 Hoffman, 2003, Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma, Cancer Cell, 4, 383, 10.1016/S1535-6108(03)00273-3 Joyce, 2003, Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis, Cancer Cell, 4, 393, 10.1016/S1535-6108(03)00271-X Rajotte, 1998, Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display, J Clin Invest, 102, 430, 10.1172/JCI3008 Zhang, 2005, Molecular profiling of heart endothelial cells, Circulation, 112, 1601, 10.1161/CIRCULATIONAHA.104.529537 Kolonin, 2006, Synchronous selection of homing peptides for multiple tissues by in vivo phage display, FASEB J, 20, 979, 10.1096/fj.05-5186fje Liu, 2003, In vivo interrogation of the molecular display of atherosclerotic lesion surfaces, Am J Pathol, 163, 1859, 10.1016/S0002-9440(10)63545-6 Zhang, 2006, Lymphatic zip codes in premalignant lesions and tumors, Cancer Res, 66, 5696, 10.1158/0008-5472.CAN-05-3876 Koivunen, 1995, Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins, Biotechnology, 13, 265, 10.1038/nbt0395-265 Laakkonen, 2002, A tumor-homing peptide with a lymphatic vessel-related targeting specificity, Nat Med, 8, 751, 10.1038/nm720 Laakkonen, 2004, Antitumor activity of a homing peptide that targets tumor lymphatics and tumor cells, Proc Natl Acad Sci USA, 101, 9381, 10.1073/pnas.0403317101 Esko, 1985, Animal cell mutants defective in glycosaminoglycan biosynthesis, Proc Natl Acad Sci USA, 82, 3197, 10.1073/pnas.82.10.3197 El-Sheikh, 2002, A novel vascular endothelial growth factor heparin-binding domain substructure binds to glycosaminoglycans in vivo and localizes to tumor microvascular endothelium, Cancer Res, 62, 7118 Järvinen, 1976, Healing of a crush injury in rat striated muscle. 3. A microangiographical study of the effect of early mobilization and immobilization on capillary ingrowth, Acta Pathol Microbiol Scand, 84A, 85 Thompson, 1991, Fibrinolysis and angiogenesis in wound healing, J Pathol, 165, 311, 10.1002/path.1711650406 Dyson, 1992, Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair, J Invest Dermatol, 99, 729, 10.1111/1523-1747.ep12614460 Paavonen, 2000, Vascular endothelial growth factor receptor-3 in lymphangiogenesis in wound healing, Am J Pathol, 156, 1499, 10.1016/S0002-9440(10)65021-3 Altschul, 1997, Gapped BLAST and PSI-BLAST: a new generation of protein database search programs, Nucleic Acid Res, 25, 3389, 10.1093/nar/25.17.3389 Joliot, 2005, Transduction peptides within naturally occurring proteins, Sci STRE, 313, pe54 Zorko, 2005, Cell penetrating peptides: mechanism and kinetics of cargo delivery, Adv Drug Deliv Rev, 57, 529, 10.1016/j.addr.2004.10.010 Porkka, 2002, A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo, Proc Natl Acad Sci USA, 99, 7444, 10.1073/pnas.062189599 Christian, 2003, Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels, J Cell Biol, 163, 871, 10.1083/jcb.200304132 Zurita, 2004, Combinatorial screenings in patients: the interleukin-11 receptor as a candidate target in the progression of human prostate cancer, Cancer Res, 64, 435, 10.1158/0008-5472.CAN-03-2675 Casanovas, 2005, Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors, Cancer Cell, 8, 299, 10.1016/j.ccr.2005.09.005 Jain, 2005, Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy, Science, 307, 58, 10.1126/science.1104819 van den Born, 2005, Novel heparan sulfate structures revealed by monoclonal antibodies, J Biol Chem, 280, 20516, 10.1074/jbc.M502065200 Freeman, 2005, Use of sulfated linked cyclitols as heparin sulfate mimetics to probe the heparin/heparin sulfate binding specificity of proteins, J Biol Chem, 280, 8842, 10.1074/jbc.M410769200 Kreuger, 2006, Interactions between heparin sulfate and proteins; the concept of specificity, J Cell Biol, 174, 323, 10.1083/jcb.200604035 Dawson, 1997, CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells, J. Cell Biol, 138, 707, 10.1083/jcb.138.3.707 Iruela-Arispe, 1999, Inhibition of angiogenesis by thrombospondin-1 is mediated by 2 independent regions within the type 1 repeats, Circulation, 100, 1423, 10.1161/01.CIR.100.13.1423